Volume 11, Issue 6 pp. 683-692
ORIGINAL ARTICLE

Molecular and Functional Characterization of Rare CACNA1C Variants in Sudden Unexplained Death in the Young

Brittan S. Sutphin BA

Brittan S. Sutphin BA

Department of Molecular Pharmacology & Experimental Therapeutics, Windland, Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, Minn, USA

Search for more papers by this author
Nicole J. Boczek PhD

Nicole J. Boczek PhD

Department of Molecular Pharmacology & Experimental Therapeutics, Windland, Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, Minn, USA

Search for more papers by this author
Héctor Barajas-Martínez MSc, PhD

Héctor Barajas-Martínez MSc, PhD

Department of Molecular Genetics, Masonic Medical Research Laboratory, Utica, N.Y., USA

Search for more papers by this author
Dan Hu MD, PhD

Dan Hu MD, PhD

Department of Molecular Genetics, Masonic Medical Research Laboratory, Utica, N.Y., USA

Search for more papers by this author
Dan Ye MD

Dan Ye MD

Department of Molecular Pharmacology & Experimental Therapeutics, Windland, Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, Minn, USA

Search for more papers by this author
David J. Tester BS

David J. Tester BS

Department of Molecular Pharmacology & Experimental Therapeutics, Windland, Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, Minn, USA

Search for more papers by this author
Charles Antzelevitch PhD

Charles Antzelevitch PhD

Department of Molecular Genetics, Masonic Medical Research Laboratory, Utica, N.Y., USA

Search for more papers by this author
Michael J. Ackerman MD, PhD

Corresponding Author

Michael J. Ackerman MD, PhD

Department of Molecular Pharmacology & Experimental Therapeutics, Windland, Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, Minn, USA

Departments of Medicine (Division of Cardiovascular Diseases) and Pediatrics (Division of Pediatric Cardiology), Mayo Clinic, Rochester, Minn, USA

Corresponding Author: Michael J. Ackerman, MD, PhD, Mayo Clinic Windland Smith Rice Sudden Death Genomics Laboratory, Guggenheim 501, Mayo Clinic, Rochester, Minn 55905, USA. Tel: 507-284-0101; Fax: 507-284-3757; E-mail: [email protected]Search for more papers by this author
First published: 24 May 2016
Citations: 21

The first four authors contributed equally to this work.

Conflict of interest: Mayo Clinic and MJA receive sales based royalties from Transgenomic's FAMILION-LQTS and FAMILION-CPVT genetic tests.

Funding: This work was supported by the Windland Smith Rice Comprehensive Sudden Cardiac Death Program (M.J.A.), the Dr. Scholl Foundation (M.J.A), Hannah Wernke Memorial Foundation (M.J.A), the Sheikh Zayed Saif Mohammed Al Nahyan Fund in Pediatric Cardiology Research (M.J.A.) CONACYT, Mexico #FM201866 (H.B.M. and D.H.), and the National Institutes of Health (R01-HD42569 to M.J.A. and R01-HL47678 to C.A.). N.J.B was supported by CTSA Grant (ULI TR000135) from the National Center for Advancing Translational Science, a component of the National Institutes of Health, and an individual PhD predoctoral fellowship from the American Heart Association (12PRE1134005).

Abstract

Introduction

Perturbations in the CACNA1C-encoded L-type calcium channel α-subunit have been linked recently to heritable arrhythmia syndromes, including Timothy syndrome, Brugada syndrome, early repolarization syndrome, and long QT syndrome. These heritable arrhythmia syndromes may serve as a pathogenic basis for autopsy-negative sudden unexplained death in the young (SUDY). However, the contribution of CACNA1C mutations to SUDY is unknown.

Objective

We set out to determine the spectrum, prevalence, and pathophysiology of rare CACNA1C variants in SUDY.

Methods

Mutational analysis of CACNA1C was conducted in 82 SUDY cases using polymerase chain reaction, denaturing high-performance liquid chromatography, and direct sequencing. Identified variants were engineered using site-directed mutagenesis, and heterologously expressed in TSA-201 or HEK293 cells.

Results

Two SUDY cases (2.4%) harbored functional variants in CACNA1C. The E850del and N2091S variants involve highly conserved residues and localize to the II-III linker and C-terminus, respectively. Although observed in publically available exome databases, both variants confer abnormal CaV1.2 electrophysiological characteristics. Examination of the electrophysiological properties revealed the E850del mutation in CACNA1C led to a 95% loss-of-function in ICa, and the N2091S variant led to a 105% gain-of-function in ICa. Additionally, N2091S led to minor kinetic alterations including a −3.4 mV shift in V1/2 of activation.

Conclusion

This study provides molecular and functional evidence that rare CACNA1C genetic variants may contribute to the underlying pathogenic basis for some cases of SUDY in either a gain or loss-of-function mechanism.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.